Home Cart Sign in  
Chemical Structure| 593960-11-3 Chemical Structure| 593960-11-3

Structure of PIK-93
CAS No.: 593960-11-3

Chemical Structure| 593960-11-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PIK-93 is the potent, synthetic PI4K (PI4KIIIβ) inhibitor with IC50 of 19 nM, and shown to inhibit PI3Kα with IC50 of 39 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PIK-93

CAS No. :593960-11-3
Formula : C14H16ClN3O4S2
M.W : 389.88
SMILES Code : CC(NC1=NC(C)=C(C2=CC=C(Cl)C(S(=O)(NCCO)=O)=C2)S1)=O
MDL No. :MFCD12922510
InChI Key :JFVNFXCESCXMBC-UHFFFAOYSA-N
Pubchem ID :6852167

Safety of PIK-93

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Related Pathways of PIK-93

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
DA neurons 250 nM 24 h Reduced DA neuronal loss and partially rescued backward locomotion defects elegans Model of ALS8. Sci Rep.
H1975 cells 1 μM 24 h PIK-93 significantly reduced PD-L1 expression in H1975 cells with little cytotoxicity. Sci Adv. 2023 Apr 7;9(14):eade9944.
M1 macrophages 10 μM 24 h PIK-93 reduced PD-L1 expression on M1 macrophages and enhanced their tumor-killing function. Sci Adv. 2023 Apr 7;9(14):eade9944.
HEK293 cells 10 µM 24 h To identify the cellular target of PIK-93 through siRNA screening, results showed that PIK-93 inhibits PV replication by targeting PI4KB activity. J Virol. 2011 Mar;85(5):2364-72.
RD cells 10 µM 7 h To evaluate the inhibitory effect of PIK-93 on PV pseudovirus infection, results showed that PIK-93 significantly inhibited PV pseudovirus infection. J Virol. 2011 Mar;85(5):2364-72.
A7r5 cells 300 nM 20 min PIK-93 inhibits PI3K, reducing vasopressin-induced translocation of TRPC6 to the plasma membrane and calcium influx. J Biol Chem. 2012 May 18;287(21):17672-17681.
T6.11 cells 300 nM 20 min PIK-93 inhibits PI3K, reducing carbachol-induced translocation of TRPC6 to the plasma membrane and calcium influx. J Biol Chem. 2012 May 18;287(21):17672-17681.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice CT26 syngeneic mouse model Intraperitoneal injection 60 mg/kg Once every other day for 2 weeks Combined PIK-93 and anti–PD-L1 antibody treatment significantly inhibited tumor growth and increased tumor-infiltrating lymphocyte recruitment. Sci Adv. 2023 Apr 7;9(14):eade9944.
C. elegans Vpr-1 knockdown model Liquid culture 250 nM Daily supplementation until Day 10 Reduced DA neuronal loss and partially rescued backward locomotion defects elegans Model of ALS8. Sci Rep.
C. elegans Vpr-1 knockdown model Liquid culture 250 nM Supplemented every 24 h until the end of the experiment PIK-93 significantly reduced the frequency of DA neuronal loss caused by the knockdown of vpr-1 in these neurons and partially rescued the backward locomotion defect, suggesting that inhibiting PtdIns4P synthesis can delay neuronal loss. elegans Model of ALS8. Sci Rep.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.56mL

0.51mL

0.26mL

12.82mL

2.56mL

1.28mL

25.65mL

5.13mL

2.56mL

References

 

Historical Records

Categories